Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Software
  • Real Estate
  • Information Technology
  • Business
Washingtoner

Torres Law Named Trade & Customs Law Firm of the Year
Washingtoner/10117975

Trending...
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 103
  • Resident Inspect Expands Virtual Property Inspections With AppFolio and Rentvine Integrations
  • Are the Cameras in Spokane Flock or ALPRs?
2021 Gle Annual Awards Winner Torres Law, PLLC
WASHINGTON & DALLAS - Washingtoner -- We are delighted to announce that the 2021 Global Law Experts Annual Awards named Torres Law, PLLC as its 2021 Trade & Customs Law Firm of the Year in the United States.

Since 2010, the Global Law Experts annual awards have celebrated excellence, innovation, and performance in legal communities around the world. Global Law Experts selects winners through a vigorous process, soliciting votes, and researching firms, and collecting supporting evidence gathered by their own in-house research team. This comprehensive selection process ensures that award recipients – local, regional, and global firms – truly represent their markets and are at the cutting edge of the practice.

More on Washingtoner
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England

Torres Law is a U.S. law firm that works with U.S. and global clients – from multinationals and Fortune 500 companies to medium-sized businesses and start-ups – to successfully import and export goods, technology, and services. The firm regularly helps clients seeking to navigate regulatory challenges posed by U.S. and foreign trade policies, including China tariffs, Iran sanctions, and the export of defense-related goods and controlled or emerging technologies.

The firm has broad experience assisting clients with a wide range of foreign investment matters, including with review by the Committee on Foreign Investment in the United States. In addition, Torres Law guides clients across the full spectrum of trade and national security law issues, from U.S. export control and economic sanctions laws to trade policy, industrial security, the Defense Federal Acquisition Regulation Supplement, Foreign Corrupt Practices Act, anti-boycott laws, customs law, and trade strategy and policy.

More on Washingtoner
  • K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026
  • Community Days at Spokane City Council Celebrating Veteran's Day
  • Dr. Latorial Faison Appointed Poet Laureate of Virginia
  • Sparta Services Named to CRN's 2026 AI Innovators List
  • AdLeverage Brings Golf Simulator Contest and Home Services Marketing Expertise to Service World Expo 2026

To assist clients with challenges across the world, Torres Law is a member of two widely recognized international associations: the International Lawyers Network, a global law firm network of more than 90 law firms in 67 countries; and Alliott Group, the world's 6th largest multidisciplinary alliance of accounting and law firms. These associations allow the firm to combine local expertise with a global reach to provide clients effective cross-border solutions.

To assist with risk advisory, audits, and complex investigations, the law firm's affiliate Torres Trade Advisory, LLC provides support by giving Torres Law access to experienced trade and national security advisors, including a network of former senior leadership in U.S. government regulatory agencies and security positions.

Contact
Veronica Ochoa
***@torrestradelaw.com


Source: Torres Law

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Haven Treatment Center Pays It Forward with Donation of 150 Food Boxes and Gift Cards to Evergreen
  • AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
  • Steve Weclew is Appointed by STS Capital Partners as Managing Director
  • ThriveStack citedby launches Prompt Research to find the prompts buyers ask in AI search
  • New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874
  • Tacoma: OMWBE Active Certification Class on November 16
  • Ornamental Designer Pro to Attend METALfab 2027, Sponsor Wednesday Opening Reception
  • The Case For Civil Disagreement
  • Resident Inspect Expands Virtual Property Inspections With AppFolio and Rentvine Integrations
  • Unlocking the Next Phase of Growth with New AI Innovations; Targeting 2027 as Breakeven; Revenue Momentum Accelerates: ZenaTech (N A S D A Q: ZENA)
  • AeroNet Deploys netElastic vBNG and CGNAT with Tarana Wireless to Deliver Scalable, Fiber-Class Broadband Across Puerto Rico
  • New Atlas Maps the 38 States Behind Every Conversation
  • Atlanta Company Launches Free, Ad-Free, Nonpartisan Voter Planning App for All 50 States Ahead of the Nov. 3 Election
  • NECP Promotes Chertova to Senior Business Analyst
  • Security Industry Veteran Anthony Rumore Launches AegisLead to Help Security Companies Find Business and Manage Growth
  • Charlie Shaw and Patrick Carragher win SEO Agency of the Year 2026
  • Canadian Woman Plants 1,667 Love Stories in a Field of Peonies That Could Bloom for 100 Years
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 264
  • Spokane: City to provide asbestos testing, host community resource meetings - 216
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process - 180
  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 137
  • Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 120
  • Final Week to Register for Free Spokane Community Conference - 120
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 103
  • Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026 - 102
  • Holiday Gambling Spending Expected to Rise 12% in December
  • Spokane Police Respond to Fatal Stabbing in Northeast Spokane

Similar on Washingtoner

  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026
  • TradeJARnal Launches Innovative Trading Journal to Help Stock and Options Traders Build Discipline and Smarter Trading Habits
  • Pursant Founder Mark Herbick Joins STS Capital Partners as CEO
  • Tampa Web Design Launches New Website for Entrepreneur and Capital Markets Advisor Martin Sumichrast
  • UK Financial Ltd. Announces Maya Preferred PRA as First Fully Verified Asset on MAYA CHAIN; Chainlink Proof of Reserve Integration Planned for Network
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
  • Steve Weclew is Appointed by STS Capital Partners as Managing Director
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute